CONVERTIBLE SECURED NOTE PURCHASE AGREEMENTConvertible Secured Note Purchase Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT (this "Agreement") is made as of October 4, 2002, by and among ALLIANCE PHARMACEUTICAL CORP., a New York corporation (the "Company") and the Holders signatory hereto (each a "Holder" and, collectively, the "Holders").
WITNESSETHGeneral Collateral Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
GENERAL COLLATERAL SECURITY AGREEMENTGeneral Collateral Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
GENERAL COLLATERAL SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ___________________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined)(collectively, the "Secured Parties").
IMAGENT SECURITY AGREEMENTImagent Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
IMAGENT SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ____________ __________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined) (collectively, the "Secured Parties").
IMAGENT AND OXYGENT PATENT AND TRADEMARK SECURITY AGREEMENTImagent and Oxygent Patent and Trademark Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
IMAGENT AND OXYGENT PATENT AND TRADEMARK SECURITY AGREEMENT dated as of October 4, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), to ____________ __________, as Collateral Agent (the "Collateral Agent") for the benefit of the holders of the Notes (as hereinafter defined) (collectively, the "Secured Parties").
WITNESSETHDebenture Imagent and Oxygent Patent and Trademark Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
WITNESSETHDebenture Imagent Security Agreement • October 9th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
ContractAlliance Pharmaceutical Corp • October 9th, 2002 • In vitro & in vivo diagnostic substances • New York
THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR EXEMPTION FROM REGISTRATION UNDER THE FOREGOING LAWS.
